The content on this site is intended for healthcare professionals only
OncoAlert Colloquium Day 5: Genitourinary tumours and social media
Published: 23 Dec 2020
Views: 449
Dr McBride, Dr Apolo, Dr Choueiri, Dr Morgan, Dr Agarwal
We present Day 5 of the OncoAlert Colloquium 2020 cancer roundups.
Day 5 features presentations on genitourinary tumours, and a special presentation on the use of social media with oncology
- Categories:
- Prostate & urology
- Patient empowerment
- Personalised medicine
- Psychosocial
- Care
- Economics
- Global health & cancer
- Low-middle income
- Medicines
- Organisation of cancer
- Prevention
- R&D
- Regulatory
- Science domains
- Social determinants
- Technology & innovation
- Training & development
- Bioinformatics
- Biology
- Biomarkers
- Causes of cancer
- Control, survivorships & outcomes
- Detection, diagnosis & prognosis
- Devices
- Diagnostics
- Epidemiology & prevention
- Imaging
- Screening
- Antibodies & immunotherapy
- Cell therapy & stem cells
- Complications
- Cytotoxics
- Drug development
- Hormones/endocrine
- Radiotherapy
- Supportive care
- Surgery
- Targeted molecules
- Transplantation
- Vaccines & virus
Related Videos
CheckMate 9ER: aRCC patients on nivolumab plus cabozantinib achieved deeper resp...
Dr Cristina Suarez - Vall d’Hebron University Hospital, Catalonia, Spain
6 Jun 2022
COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity i...
Dr Sumanta K. Pal - City of Hope Comprehensive Cancer Center, Duarte, USA
5 Jun 2022
War in Ukraine: Impacts on the Slovakian cancer care system
Dr Darina Sedláková - Slovak League Against Cancer, Bratislava, Slovakia
11 May 2022
WHO and St. Jude Children’s research hospital to dramatically increase global ac...
Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer Initia...
17 Dec 2021
AORTIC 2021: Goals of AORTIC
Dr Verna Vanderpuye - AORTIC 2021 Programme Director, Ghana
21 Oct 2021
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...
Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy
19 Jul 2021
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally ad...
Dr Terence Friedlander - UCSF, San Francisco, USA
4 Jun 2021
How to improve cancer prevention and screening programmes in Romania
Dr Răzvan Curcă - Alba Iulia Emergency Hospital, Alba Iulia, Romania
19 Jan 2021
PARP inhibitors and their evolving role for the treatment of prostate cancer
Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
24 Sep 2020